Shen Qi pointed to the production line and said: "Our factory's market share of Liyuexi is OK, but the total domestic volume of this market is only a few hundred million yuan, my idea is to transform the production line of Liyuexi into LPJK1 production line, which will save a lot of money than building a new production line." ”

"So LPJK1 will definitely pass the phase III clinical trial?" asked Lao Yan.

"I don't dare to be complacent, but I am confident. ”

Shen Qi gave a determined look and said, "The animal experiment on LPJK1 has been completed, and it will take a certain amount of time from now until the clinical trial is completed. I can't guarantee that LPJK1 will be approved and successfully listed, I can only say that there is hope. Lao Yan, my dad doesn't know much about technology, so it still depends on you and Lao Cheng. Liyuexi production line renovation project, you can first do a good job of research plan, once the LPJK1 side is completed, you will immediately start the production line transformation. ”

Lao Yan looked at Lao Shen and Shen Qi and asked, "In terms of technology, Lao Cheng and I should be able to handle it." I don't understand sales either, I just ask, Li Yuexi will not produce or sell in the future?"

Liyuexi (midazolam injection) is an intravenous anesthetic that is widely used in various surgeries.

Although it is widely used, as Shen Qi said, the total annual sales of Liyuexi in China are only a few hundred million yuan.

Compared with the people who take medicine all year round, the people who have surgery are a minority after all. How many surgeries can a person have in his life?

The total market share is not high on the one hand, and Shen Qi's heart disease is on the other.

OBEQI Pharmaceutical does not own any of the patents of Liyuexi, they only have the domestic production rights of Liyuexi, and they are not the only domestic pharmaceutical factory of Yuexi.

This is Shen Qi's heart disease.

For a scientist who is accustomed to being original and accustomed to owning patent rights, Shen Qi is very reluctant to let his father's factory produce and sell a product that is not original and has no patent rights.

To put it bluntly, isn't this kind of thing just doing OEM and acting as an agent with others?

dignified Shen Qi's father went to work with others and agents?

Shen Qi was unhappy.

A few years ago, when Lao Shen Gang acquired Obeqi Pharmaceutical, he was poor and had no choice but to rely on Liyuexi to barely maintain the normal operation of the factory.

With the launch of Shen Qi Laboratory's original drug Kangshuen, OBEQI Pharmaceutical is no longer what it used to be.

Intellectual property rights determine the initiative of enterprises, and enterprises without independent intellectual property rights are ultimately empty-minded.

Not only is the heart weak, but there is also the possibility of perdition.

The tigers and wolves outside have used intellectual property rights and core technologies to embarrass Chinese companies more than once, and this kind of thing has happened too much.

We don't want to fight, but we are not afraid to fight, and we have to fight when necessary.

Hit, you can hit.

But if we want to win, we must master independent intellectual property rights and core technologies, the more the better.

From the state to the enterprise, from the laboratory to the industrial site, what should be.

Lao Shen quickly gave his opinion: "According to what Shen Qi said, we will not be productive in Yuexi in the future, so we will transform the production line of Liyuexi into an original drug production line, and we will do it." Teacher Yan, thank you for your hard work. ”

"OK, understood!" After all, Lao Yan is a master of science from Yan University, and he knows very well the importance of independent intellectual property rights and core technologies.

In this way, the fate of Li Yuexi in Obeqi Pharmaceutical was decided.

Liyuexi, a Class II psychotropic drug, is strictly controlled by the state, and it is difficult to obtain production approval.

OBEQI Pharmaceutical has the domestic production approval of Liyuexi, which is very valuable.

It's a pity to scrap an extremely rare approval like this.

However, in Shen Qi's view, intellectual property rights are above all else, and the production approval without independent intellectual property rights is a bubble and a void.

Shen Qi, Lao Shen, and Lao Yan inspected a circle of Liyuexi production line, and it took a lot of money to transform this production line into LPJK1 production line.

Who will pay for this money? Of course, it will be Lao Shen.

At present, Obeqi Pharmaceuticals mainly relies on the diabetes drug Kangshuen, which is the most important asset of the pharmaceutical company. Raising medicine with medicine, a medicine feeds a factory.

"Two Boss Shen, then I'll arrange manpower to study the plan for the transformation of Liyuexi's production line?"

Shen Qi smiled: "Don't worry, old smoke, it's the twenty-sixth day of the lunar month today, and the whole factory will have a holiday the day after tomorrow, and it's not too late to study it after the New Year." Lao Yan, on the twenty-ninth day of the lunar month, you, Lao Cheng and our family of three flew to the capital together. Your wife is alone in the capital, don't you miss it?"

"Of course I'm worried, okay, on the twenty-ninth day of the lunar month, let's go together. Two Boss Shen, your father and son are chatting alone, and I will go back to the technical department to check the information. Lao Yan left and let Shen Qi and his son be alone.

"Go to the production workshop of Kangshuen and have a look. Shen Qi said.

"Let's go, over there. Lao Shen took Shen Qi to another workshop, and he said as he walked: "Kang Shuen is the lifeblood of our factory, and some foreign pharmaceutical companies have moved their minds and want to buy Kang Shuen." ”

Shen Qi nodded and said, "I know this, they have also looked for me." ”

Lao Shen suddenly became excited: "The British GLK company offered 700 million pounds to buy Kangshuen, and I scolded him back. The British are so bad, they want to get Conshuen for 700 million pounds?

Shen Qi shook his head and said, "700 million pounds, it definitely can't be sold to them." These Brits, are we mentally retarded when we are father and son?"

Lao Shen: "700 million pounds plus a zero, I may consider it." ”

Shen Qi showed an incredulous expression: "7 billion pounds? Dad, are you crazy?"

Lao Shen explained: "I know that Kang Shuen is your brainchild and the original crystallization of your laboratory, so I just make a hypothesis." ”

Shen Qi: "No, I mean, if you really want to sell Kang Shuen, 7 billion pounds plus zero is the starting price." ”

"Seven hundred...... Seven tens of billions of pounds?" Lao Shen felt that he was not crazy, the crazy person was Shen Qi.

Shen Qi explained: "Kang Shuen is the original of our laboratory, and it is indeed my hard work, if our factory is really short of money, I don't mind if you sell Kang Shuen." Dad, I'll give you a few figures, and you'll understand why Conshuen is worth more than £70 billion. ”

"Diabetes is a global disease, and last year's statistics were that diabetes accounted for 12% of global medical costs, amounting to $778.2 billion. Yes, you heard it right, people with diabetes worldwide spend close to $800 billion a year on treatment, and that number continues to rise. ”

"GLK has offered you £700 million to acquire all of Conshuen's patents, as well as the global production and sales rights. Dad, you can say to them: go to hell. ”

"Let's just talk about this GLK company, they once had a global best-selling hypoglycemic drug --- Wendia, this Wendia is amazing, in a few years, global sales went to billions of dollars. ”

Later, the FDA issued a warning that Vindia's side effects caused cardiovascular disease, and Vindia was devastated, and global sales plummeted. I have studied this case in detail, in fact, GLK is quite wronged, and Wendia is not as unbearable as the FDA accuses. A few years later, the FDA fully lifted the ban on Vindia, but at this time, the hypoglycemic drug market has been carved up by other international pharmaceutical giants, and GLK's Vindia can no longer return to peak sales. ”

"That's how the FDA is, it's better to kill by mistake than to let it go. But objectively evaluated, the FDA's review of drugs is indeed the most stringent in the world, and there is no one. ”

After Wendia cooled down, GLK was eager to get a new diabetes drug, the same level as Wendia in its heyday. That's why GLK representatives come to you and me so often, because our Conshuen is exactly what they expect. ”

"I've said so much, Dad, you understand now, Kangshuen's value proposition is to start at least 70 billion pounds. If you want to sell Kangshuen, I don't care, the old doesn't go to the new, give me a tenth of the 70 billion pounds, and I can develop ten more new drugs. The remaining nine-tenths of the way I want to do something more meaningful. ”

Lao Shen was silent, and after a long time, he took out the platinum boss signature pen and handed the pen to Shen Qi: "Come, the pen is for you, you are the boss." ”

……

……

Ask for a monthly pass and a recommended ticket!